All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry

ARS-853 (ARS853)

CAS number:1629268-00-3    molecular formula:C22H29ClN4O3

overview

compound introduction

Information ARS-853 (ARS853) ARS-853 is a selective, covalent KRAS(G12C) inhibitor that inhibits mutant KRAS-driven signaling by binding to the GDP-bound oncoprotein and preventing activation. ARS-853 also induces apoptosis . Targets K-Ras(G12C) (in H358 cells) 2.5 μM In vitro ARS-853 treatment of KRAS G12C cells led to a dose-dependent and nearly complete inhibition of CRAF-RBD (RBD)-mediated pulldown of KRAS from lysates, with an IC50 of approximately 1 μmol/L. Treatment of H358 cells by ARS-853 resulted in a significant loss of KRAS–CRAF interactions. Consistent with an inactive state of KRAS G12C once bound to ARS-853, downstream signaling through both MAPK (including pMEK, pERK, and pRSK) and PI3K signaling (pAKT) pathways was inhibited by ARS-853 in H358 and other KRAS G12C cell lines. The inhibition of RAF-RBD pulldown and KRAS downstream signaling was sustained over a period of 72 hours, accompanied by G1 cell-cycle arrest, loss of Cyclin D1 and Rb expression, and an increase in the cell-cycle inhibitor p27 KIP1. In addition, hallmarks of apoptosis, including cleaved PARP and increases in sub-diploid DNA, were observed in H358 cells following treatment with ARS-853. No effects on RAF-RBD binding or downstream signaling were observed in A549 cells (KRASG12S), and the inhibitory effects of ARS-853 in H358 cells could be rescued by ectopic expression of KRAS G12V . KRAS G12C is the most potent covalent target of ARS-853 across more than 2,700 cellular proteins and consistently find that this compound exerts no effects on cellular signaling or growth in non-KRAS G12C cells at concentrations up to 10-fold higher than its KRAS G12C potency. ARS-853 reacts only with the inactive (GDP-bound), but the not the active (GTP-bound), state of KRAS. ARS853 reduced KRAS-GTP levels and ERK phosphorylation in human embryonic kidney 293 (HEK293) or H358 cells engineered to express KRAS G12C but not in those expressing KRAS G12C/A59G . ARS853 traps KRAS G12C in a GDP-bound conformation by lowering its affinity for nucleotide exchange factors. Cell Research(from reference) Cell lines:H358 (G12C) cells Concentrations:0.05, 0.1, 0.5, 1, 5, 10, 50 μM Incubation Time:5 h

Specs

Chinese alias-
English alias2-​Propen-​1-​one,1-​[3-​[4-​[2-​[[4-​chloro-​2-​hydroxy-​5-​(1-​methylcyclopropyl)​phenyl]​amino]​acetyl]​-​1-​piperazinyl]​-​1-​azetidinyl]​-
CAS number1629268-00-3molecular formulaC22H29ClN4O3
molecular weight432.94 g/molExact mass10mM in DMSO
PSA76.100 Ųlogp2.9

numbering system

No numbering system information yet

physicochemical properties

No physical and chemical property information yet

Safety information

No safety information yet

Production methods and uses

No production method and use information yet

Related

upstream information

No upstream information yet

downstream information

No downstream information yet

MSDS

Found 0 shareMSDS